Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, 100029, China.
VIP Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100021, China.
Curr Stem Cell Res Ther. 2023;18(8):1172-1183. doi: 10.2174/1574888X18666230203162452.
The aim of this study was to identify the biological characteristics and potential roles of endometrial progenitor cells in the pathogenesis of endometriosis.
It is generally believed that progenitor cells in human endometrium are responsible for rapid endometrial regeneration. However, the biological characteristics and potential roles of the paired eutopic and ectopic endometrial progenitor cells in endometriosis remain unclear.
This study intends to isolate the epithelial progenitor (EP) cells and endometrial mesenchymal stem cells (eMSCs) from the eutopic and ectopic endometria from endometriosis patients, further to reveal their features and functions respectively.
The distributions of EP cells and eMSCs and the expression of steroid hormone receptors in the endometrium and endometriotic tissues were assessed by immunohistochemistry. EP cells and eMSCs were sorted from paired eutopic and ectopic endometria with epithelial cell adhesion molecule (EpCAM) magnetic beads. The clonogenicity, cell viability after being treated with estradiol and progesterone, and cell markers expression were evaluated with colony forming on Matrigel, CCK-8 and immunofluorescence staining, respectively. The differentially expressed genes (DEGs) were further identified with RNA sequencing.
SSEA-1- and PDGFRβ-positive cells were distributed in the epithelial and stromal layers. The ERβ staining was much more intense in endometriotic tissues, but PR expression was almost absent. The ectopic EP cells exhibit strong clonogenicity and ERβ expression but weak PR expression, leading to progesterone resistance. There are 12604 and 13242 DEGs revealed by RNA sequencing between eutopic and ectopic EP cells or eMSCs. GO and KEGG analyses revealed that the functions and pathways of DEGs enriched in cellular energy metabolism and regulation of the immune response, respectively. Additionally, ERβ targets were mainly enriched in ectopic EP cells.
Both EP cells and eMSCs may engage in ectopic lesion formation in endometriosis by modifying the metabolic mode and immune tolerance. These data not only help to understand the molecular mechanism of endometriosis but also could potentially contribute to the discovery of therapeutic targets for endometriosis.
本研究旨在确定子宫内膜祖细胞在子宫内膜异位症发病机制中的生物学特性和潜在作用。
人们普遍认为,人子宫内膜中的祖细胞负责快速子宫内膜再生。然而,子宫内膜异位症中配对的在位和异位子宫内膜祖细胞的生物学特性和潜在作用仍不清楚。
本研究拟从子宫内膜异位症患者的在位和异位子宫内膜中分离上皮祖细胞(EP)细胞和子宫内膜间充质干细胞(eMSC),进一步分别揭示其特征和功能。
采用免疫组织化学法评估子宫内膜和异位组织中 EP 细胞和 eMSC 的分布以及甾体激素受体的表达。用上皮细胞黏附分子(EpCAM)磁珠从配对的在位和异位子宫内膜中分离 EP 细胞和 eMSC。用集落形成实验、CCK-8 法和免疫荧光染色法分别评估克隆形成能力、雌二醇和孕酮处理后的细胞活力以及细胞标志物表达。进一步通过 RNA 测序鉴定差异表达基因(DEGs)。
SSEA-1-和 PDGFRβ阳性细胞分布在上皮和间质层。ERβ 在异位组织中的染色强度明显增强,而 PR 表达几乎缺失。异位 EP 细胞具有较强的克隆形成能力和 ERβ 表达,但 PR 表达较弱,导致孕酮抵抗。通过 RNA 测序发现,在位和异位 EP 细胞或 eMSC 之间有 12604 个和 13242 个 DEGs。GO 和 KEGG 分析显示,富集的 DEGs 的功能和通路分别涉及细胞能量代谢和免疫反应调节。此外,ERβ 靶基因主要富集在异位 EP 细胞中。
EP 细胞和 eMSC 可能通过改变代谢模式和免疫耐受参与子宫内膜异位症的异位病变形成。这些数据不仅有助于理解子宫内膜异位症的分子机制,而且可能有助于发现子宫内膜异位症的治疗靶点。